Loading...
AMEX: PTN
Palatin Technologies, Inc.
Healthcare · Biotechnology
Market Cap
$546.12M
52w High
$41.50
52w Low
$2.00
P/E
-2.12
Volume
1.55K
Outstanding Shares
26.01M
Company profile
Palatin Technologies, Inc., a biopharmaceutical company, develops targeted receptor-specific therapeutics for the treatment of various diseases in the United States.
CEOCarl Spana
SectorHealthcare
IndustryBiotechnology
Employees30
IPO dateOct 15, 1997
Valuation
Forward P/E—
EV/EBITDA-0.08
Enterprise value$1.37M
Stock splits
Aug 12, 20251:50
Aug 31, 20221:25
Sep 27, 20101:10
Sep 8, 19971:4
Jul 22, 19961:10
Profitability & growth
Revenue growth—
Gross margin99.25%
Operating margin-134.8%
ROE362.3%▼98.64%vs FY2024
Analyst consensus
RatingBuy
Target price$55.00▲161.90%
3
Buy
0
Hold
0
Sell
⚠ Analyst ratings tend to be lagging indicators — upgrades often follow price gains rather than precede them. Use as one signal among many.
Earnings
Last 3 reported quarters plus the next estimate. Switch into compare mode to inspect one metric year-over-year.
Next report
May 13, 2026
View
EPS
Actual vs estimate by quarter
Q3'25
ActualEst.
-$4.14
-$9.50
Q4'25
ActualEst.
$4.26
—
Q2FY26
ActualEst.
-$2.86
-$2.35
Q3FY26
Next Est.
—
Revenue
Actual vs estimate by quarter
Q3'25
ActualEst.
—
—
Q4'25
ActualEst.
$8.85M
—
Q2FY26
ActualEst.
$116.04K
$25K
Q3FY26
Next Est.
—